Janus Henderson Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,753
Closed -$1.22M 2602
2023
Q4
$1.22M Sell
20,753
-8,731
-30% -$513K ﹤0.01% 1526
2023
Q3
$1.28M Buy
29,484
+10,262
+53% +$447K ﹤0.01% 1430
2023
Q2
$695K Sell
19,222
-16
-0.1% -$578 ﹤0.01% 1803
2023
Q1
$716K Sell
19,238
-508,471
-96% -$18.9M ﹤0.01% 1814
2022
Q4
$23.9M Sell
527,709
-924,507
-64% -$41.9M 0.02% 527
2022
Q3
$101M Buy
1,452,216
+720,459
+98% +$50.3M 0.04% 357
2022
Q2
$49.1M Sell
731,757
-209,946
-22% -$14.1M 0.03% 384
2022
Q1
$77.4M Buy
941,703
+53,635
+6% +$4.41M 0.04% 375
2021
Q4
$130M Sell
888,068
-109,933
-11% -$16.1M 0.05% 304
2021
Q3
$177M Sell
998,001
-71,966
-7% -$12.7M 0.08% 254
2021
Q2
$173M Sell
1,069,967
-86,196
-7% -$13.9M 0.07% 267
2021
Q1
$198M Buy
1,156,163
+3,594
+0.3% +$616K 0.09% 221
2020
Q4
$253M Sell
1,152,569
-726,211
-39% -$160M 0.12% 185
2020
Q3
$312M Sell
1,878,780
-671,594
-26% -$112M 0.16% 146
2020
Q2
$291M Buy
2,550,374
+201,473
+9% +$23M 0.16% 141
2020
Q1
$181M Buy
2,348,901
+391,117
+20% +$30.1M 0.12% 178
2019
Q4
$252M Sell
1,957,784
-54,351
-3% -$7M 0.13% 183
2019
Q3
$157M Buy
2,012,135
+334,596
+20% +$26.1M 0.08% 257
2019
Q2
$173M Sell
1,677,539
-357,205
-18% -$36.8M 0.09% 245
2019
Q1
$149M Buy
2,034,744
+956,022
+89% +$70.1M 0.08% 279
2018
Q4
$45.8M Buy
1,078,722
+52,955
+5% +$2.25M 0.03% 562
2018
Q3
$48.3M Buy
1,025,767
+363,728
+55% +$17.1M 0.03% 600
2018
Q2
$32.6M Buy
+662,039
New +$32.6M 0.02% 671